Christina Ackermann
CIK 1681871 · Please see remarks · last filed 2025-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BHC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NJ 08807
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) Delisted | Director | 0 | $106.91 | $0 | -$163.0K | 7 | 2025-10-08 |
| CALC | Director | 286 | $1.20 | $343 | $0 | 1 | 2023-03-27 |
| BLCO | Please see remarks | 146,677 | $20.73 | $3.04M | $0 | 3 | 2023-03-03 |
| CalciMedica, Inc. (GRAY) Delisted | Director | — | $5.50 | — | $0 | 3 | 2022-06-03 |
| BHC | EVP AND GENERAL COUNSEL | 162,240 | $8.58 | $1.39M | -$4.45M | 23 | 2022-03-11 |
Recent Filings · Page 2 of 5
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-03 | BLCO | Grant (A) | +28,344 | $0 | EDGAR |
| 2022-07-27 | BLCO | Grant (A) | +35,000 | $0 | EDGAR |
| 2022-06-03 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-09 | BLCO | Grant (A) | +83,333 | $0 | EDGAR |
| 2022-03-11 | BHC | Tax (F) | −839 | -$18.9K | EDGAR |
| 2022-03-07 | BHC | Tax (F) | −6,926 | -$163.5K | EDGAR |
| 2022-03-02 | BHC | Mixed | +8,264 | -$390.3K | EDGAR |
| 2021-08-31 | BHC | Tax (F) | −5,017 | -$145.2K | EDGAR |
| 2021-06-04 | CalciMedica, Inc. (GRAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | BHC | Mixed | — | -$2.06M | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).